ICER Doubles Down on Flawed Metrics

How much is a life worth? It’s not an easy question, but that doesn’t stop the Institute for Clinical and Economic Review from trying to calculate an answer – even if it means using biased tools. Learn More

Thyroid Eye Disease in the Spotlight

Thyroid Eye Disease Awareness Week is the perfect time to recognize the voices of patients and caregivers affected by the rare and debilitating – but treatable – autoimmune condition. Learn More

This April, Women’s Eyes Have It

Most Americans are probably aware that men die at a younger age than women, get sick more often and are more likely to suffer from heart disease and other chronic conditions. But this familiar narrative can mislead women about some of the disproportionate risks to their health. One area with a large “reverse health gap” is the eyes. Read more on Health Policy Today.

Would You Recognize Thyroid Eye Disease?

Eye bulging, double vision, watery eyes and debilitating eye pain. Any one of these symptoms is reason to visit an eye doctor, but together they could signify thyroid eye disease. Read more on Health Policy Today.

Insurers Push for Cheaper, Untested Eye Treatment

Injecting a syringe of an unapproved treatment into a patient’s eyeball would be a nightmare scenario for most ophthalmologists. But that is what many major insurance companies are now suggesting doctors do. Read more on Health Policy Today.

Are Insurers Slighting Sjögren’s Patients?

By Susan Barajas When you have a disease nobody has heard of, it’s easy to feel alone. And when insurance companies make it harder for you to access treatment, it can become even more disheartening. I know these feelings all too well.  Read more on Health Policy Today.

Drug Shortage Distress

With the nation’s attention riveted on the distribution of COVID-19 vaccines, drugs that allow patients to deal with other serious medical conditions are falling by the wayside. But it doesn’t need to be that way. Read more on Health Policy Today.

Load More Posts